Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Lung Neoplasms and MUC16[original query] |
---|
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors. JAMA network open 2020 Aug 3 (8): e2013201. Zhang Lei, Han Xiaohong, Shi Yuank |
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma. Translational lung cancer research 2021 3 10 (2): 699-711. Kang Minsu, Park Changhee, Kim Se Hyun, Yoon Sock Won, Suh Koung Jin, Kim Yu Jung, Ock Chan-Young, Kim Miso, Keam Bhumsuk, Kim Tae Min, Kim Dong-Wan, Heo Dae Seog, Lee Jong Se |
Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression. Aging 2021 2 13 (6): 8706-8719. Zhou Chengmao, Wang Yongsheng, Wang Ying, Lei Lei, Ji Mu-Huo, Zhou Guoren, Xia Hongping, Yang Jian-J |
Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma. Frontiers in cell and developmental biology 2021 11 9 761758. Xie Xiaona, Tang Yemeng, Sheng Jueqi, Shu Pingping, Zhu Xiayan, Cai Xueding, Zhao Chengguang, Wang Liangxing, Huang Xiaoyi |
Circulating tumor DNA predicts the outcome of chemotherapy in patients with lung cancer. Thoracic cancer 2021 11 13 (1): 95-106. Zhang Min, Huang Chao, Zhou Huan, Liu Dan, Chen Runze, Li Xiuhua, Cheng Ye, Gao Bing, Chen J |
Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer. Computational and mathematical methods in medicine 2021 2021 1522250. Hu Sizhe, Zhao Xiaokang, Qian Feng, Jin Cancan, Hou Kaish |
Lead DEAD/H box helicase biomarkers with the therapeutic potential identified by integrated bioinformatic approaches in lung cancer. Computational and structural biotechnology journal 2021 1 19 261-278. Cui Yuxin, Hunt Adam, Li Zhilei, Birkin Emily, Lane Jane, Ruge Fiona, Jiang Wen |
Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 40 (34): 3912-3917. Yue Dongsheng, Xu Shidong, Wang Qun, Li Xiaofei, Shen Yi, Zhao Heng, Chen Chun, Mao Weimin, Liu Wei, Liu Junfeng, Zhang Lanjun, Ma Haitao, Li Qiang, Yang Yue, Liu Yongyu, Chen Haiquan, Zhang Zhenfa, Zhang Bin, Wang Chang |
Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study. Medicine 2023 11 102 (44): e35481. Tingjun Liu, Lianlian Wu, Jing Liu, Hao Chen, Bao Zhu, Dandan Qiao, Yuhua Zhu, Tingya Liu, Quangang Chen, Ankang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: